Evidence map›Paper›PMID 40815156›Full record

ArticleMicrobiology spectrum2025

Occurrence of KPC-71 or the presence of NDM combined with a high expression of

Hanxu Hong, Yuxuan Liu, Linping Fan, Bowen Shi, Ruihang Luo, Chenye Xi, Zhuoyuan Yang, Wenjing Yang, Xinyi Zeng, DanDan Wei and 1 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Genetic characterization of carbapenem-resistantFrontiers in cellular and infection microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hanxu HongDepartment of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.ORCID 0009-0005-0937-429X
Yuxuan LiuDepartment of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.ORCID 0000-0003-1239-0539
Linping FanDepartment of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Bowen ShiFirst Clinical Medical College, Nanchang University, Nanchang, China.
Ruihang LuoFirst Clinical Medical College, Nanchang University, Nanchang, China.
Chenye XiCollege of Stomatology, Nanchang University, Nanchang, China.
Zhuoyuan YangSecond Clinical Medical College, Nanchang University, Nanchang, China.
Wenjing YangFirst Clinical Medical College, Nanchang University, Nanchang, China.
Xinyi ZengFirst Clinical Medical College, Nanchang University, Nanchang, China.
DanDan WeiDepartment of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Yang LiuDepartment of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.ORCID 0009-0009-1869-3558

Funding

National Natural Science Foundation of China 32370195National Natural Science Foundation of China 82102411National Natural Science Foundation of China 82260403
6 · The paper itself

Abstract

Low-level cefiderocol (CFDC) resistance in carbapenem-resistant

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeCephalosporinsKlebsiella InfectionsKlebsiella pneumoniaeAzabicyclo CompoundsCarbapenemsCefiderocolChinaDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsPhylogenyPlasmidsAnti-Bacterial AgentsAzabicyclo CompoundsBacterial Proteinsbeta-LactamasesCarbapenemsCefiderocolCephalosporinscarbapenem-resistant Klebsiella pneumoniaecefiderocolhigh expression of blaSHVKPC-71low-level resistance

Identifiers

PMID40815156
PMCPMC12502687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.